News

The use of broad-panel, next-generation sequencing (NGS) proved to be more cost-effective than single-gene testing in patients with non-squamous non-small cell lung cancer, according to a study presented during the recent American Society of Clinical Oncology (ASCO) virtual meeting. In this exclusive MedPage Today video, the study’s lead author, Nathan A. Pennell, MD, PhD, of
0 Comments
Obesity and metabolism-related diseases have become “the world’s biggest health problems,” taking the lives of at least 2.8 million each year, according to Healthline. To combat both, many diets have emerged, only a few of which are backed by research.  One of these science-backed diets is the ketogenic diet, a low-carb, high-fat diet. Because consumption
0 Comments
Glycemic control among youth with diabetes is no better today than it was in 2002 and in some subgroups it’s worse, despite increased availability of diabetes technology, newer therapies, and more aggressive recommended blood glucose targets, new research finds. The sobering data from 6399 participants in the longitudinal SEARCH for Diabetes in Youth study were
0 Comments
When COVID-19 began spreading rapidly across the United States, government officials responded with stay-at-home orders, business closures, cancellations of elective procedures, and many other unprecedented measures to slow the spread of the virus. Yet, as Americans did their part to social distance and protect their neighbors and loved ones, kidney patients, and particularly those on
0 Comments
Before patients with cancer begin treatment with intravenous fluorouracil and related drugs, they should be tested for lack of the enzyme dihydropyrimidine dehydrogenase (DPD), says an EU panel. This enzyme is involved in the metabolism of fluorouracil, as well as the related drugs capecitabine (Xeloda, Genentech) and tegafur, which are converted to fluorouracil in the
0 Comments